All patients receiving DDAVP Nasal Spray should be observed for the following signs or symptoms associated with hyponatremia: headache, nausea/vomiting, decreased serum sodium, weight gain, restlessness, fatigue, lethargy, disorientation, depressed reflexes, loss appetite, irritability, muscle weakness, muscle spasms or cramps and abnormal mental status such as hallucinations, decreased consciousness, and confusion
Biogerontology 20(3):279301
Heres what Midis medical experts recommend: Lose weight: Consider GLP-1s, like semaglutide or tirzepatide
Melatonin inhibits apoptosis in mouse Leydig cells via the retinoic acid-related orphan nuclear receptor /p53 pathway